-+ 0.00%
-+ 0.00%
-+ 0.00%

ROYALTY PHARMA : LITIFILIMAB IS CURRENTLY IN PHASE 3 TRIALS FOR BOTH SLE AND CLE WITH RESULTS EXPECTED BETWEEN 2026 AND 2027

Reuters·02/12/2025 11:30:00

Please log in to view news